Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02579811
Title Axitinib Given on an Individualized Schedule for Metastatic Renal Cell Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Case Comprehensive Cancer Center
Indications

clear cell renal cell carcinoma

Therapies

Axitinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.